Value Motion Overview:
The Nifty Chemical substances Index staged a powerful rebound in April 2026 amid enhancing international sentiment following the ceasefire announcement throughout the ongoing West Asia battle, though no formal settlement has been signed to this point. The index considerably outperformed the broader market, rebounding 14.21% in April 2026 in comparison with Nifty’s 7.46% restoration, reflecting sturdy sectoral momentum and renewed shopping for curiosity. Regardless of lingering geopolitical tensions in West Asia, the Chemical substances Index has managed to maintain most of its positive aspects and continues to stay in a transparent uptrend on the day by day timeframe.
Technically, the index witnessed delicate revenue reserving close to the 29,900 zone following its all-time excessive breakout, however it efficiently held the essential help area round 28,600 and located help close to the 20-day EMA (28,657), indicating a wholesome retracement. The index additionally continues to commerce comfortably above the 50-day EMA positioned close to 28,056, reflecting sustained medium-term energy. The day by day RSI (14) stands at 61.6 and stays above the impartial 50 mark, signalling continued bullish momentum regardless of short-term consolidation. Sustaining above the 28,600 help zone may result in a retest of the current swing excessive close to 29,900, and doubtlessly a transfer above the psychological 30,000 mark within the coming months.
Development Evaluation:
From January to March 2026, the Nifty Chemical substances Index corrected almost 14% amid escalating West Asia tensions, rising crude oil costs and weak international chemical demand. Nonetheless, sentiment reversed sharply in April after the ceasefire announcement, regardless of no formal settlement being signed. The index staged a robust V-shaped restoration, reclaiming the whole three-month decline inside a single month and breaking above its earlier all-time excessive. Regardless of Brent crude closing close to $109 per barrel and the Rupee hitting a document low of ₹96.5 in opposition to the US greenback, the index continues to indicate energy with a transparent larger excessive & larger low construction, signalling the broader uptrend stays intact.
Business Evaluation:
India’s chemical business continues to indicate sturdy long-term progress potential pushed by rising home demand, coverage help and growing investments. India is presently the sixth-largest chemical producer globally and third in Asia, contributing almost 7% to the nation’s GDP. In response to McKinsey, India’s chemical substances and petrochemicals demand may almost triple to USD 1 trillion by 2040. Export momentum additionally stays sturdy, with shipments touching USD 9.19 billion throughout FY26 (April–June). Authorities initiatives such because the PLI scheme and PCPIR initiatives are boosting investments and infrastructure growth. In the meantime, rising alternatives in specialty chemical substances, inexperienced solvents and biodegradable merchandise are positioning India as a key various to China in international provide chains.
Main Picks within the Chemical substances Area:
- CHEMICAL – Kotak Nifty Chemical substances ETF.
- SOLARINDS.
- PIDILITIND.
Conclusion:
The Nifty Chemical substances Index continues to exhibit sturdy relative energy after a pointy V-shaped restoration from the March lows, signalling continuation of the broader uptrend. The index has recovered its total three-month decline, whereas holding above the 20-day EMA, retaining the bullish construction intact. A breakout above 29,900 may set off a rally past the psychological 30,000 mark. Nonetheless, rising West Asia tensions, elevated crude costs, and Rupee weak spot stay key dangers for the sector.
Key helps: 28,600 / 28,000 / 27,350.
Disclaimer: Investments within the securities market are topic to market dangers, learn all associated paperwork rigorously earlier than investing. Securities quoted listed here are exemplary, not recommendatory. Please seek the advice of your monetary advisor earlier than investing. Please notice that we don’t assure any assured returns for the securities quoted right here.
Analysis disclaimer: Funding within the securities market is topic to market dangers. Learn all of the associated paperwork rigorously earlier than investing. Registration granted by SEBI, and certification from NISM by no means assure the efficiency of the middleman or present any assurance of returns to buyers.
For extra particulars, please learn the disclaimer.
Different articles you could like
Submit Views:
34
